OPN could be a target for tumor prevention under weak and chronic inflammation, such as in obesity, but when there are severe injury and acute inflammation, complete depletion of OPN should not be recommended. The gene discussed is SPP1; the disease is obesity due to melanocortin 4 receptor deficiency.